Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice

被引:76
作者
Mokhtarian, F
Zhang, ZG
Shi, Y
Gonzales, E
Sobel, RA
机构
[1] SUNY Hlth Sci Ctr, Dept Med, Div Immunol, Brooklyn, NY 11219 USA
[2] Maimonides Med Ctr, Brooklyn, NY 11219 USA
[3] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA
[4] VA Hlth Care Syst, Palo Alto, CA USA
关键词
autoimmune demyelinating disease; Semliki Forest Virus; multiple sclerosis;
D O I
10.1016/S0165-5728(98)00254-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Semliki Forest Virus (SFV) induces an encephalomyelitis followed by demyelination in the brains of C57B16/J (B6) mice. To investigate the role of molecular mimicry in the pathogenesis of postviral demyelination, alignment algorithms were used and amino acid homologies between immunogenic epitopes of SFV and myelin autoantigens, myelin basic protein (MBP), myelin proteolipid protein (PLP) and myelin oligodendrocyte glycoprotein (MOG) were identified. Immunization of B6 mice with SFV proteins induced significant lymphocyte proliferation to SFV E2 peptides and to MOG peptide,18-32 (which had molecular mimicry with E2 115-129), but not to MBP or PLP peptides. Both MOG 18-32 and E2 115-129, induced a later-onset chronic EAE-like disease that correlated with the presence of multifocal vacuolation in the CNS white matter. This histopathology was reminiscent of the secondary demyelination seen following SFV infection. Serum antibody responses to the peptides appeared late after immunizations and some samples cross-reacted with other myelin peptides, as well as with the mimicked MOG peptides. These findings suggest that following a CNS viral infection, antibody response to an epitope of virus that exhibits molecular mimicry with a peptide of MOG may contribute to autoimmune mediated injury to CNS myelin. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:43 / 54
页数:12
相关论文
共 41 条
[1]  
AMOR S, 1994, J IMMUNOL, V153, P4349
[2]   ANTIGENIC-COMPETITION AT THE LEVEL OF PEPTIDE-IA BINDING [J].
BABBITT, BP ;
MATSUEDA, G ;
HABER, E ;
UNANUE, ER ;
ALLEN, PM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) :4509-4513
[3]  
BERAUD E, 1986, J IMMUNOL, V136, P511
[4]   CHRONIC RELAPSING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS WITH A DELAYED-ONSET AND AN ATYPICAL CLINICAL COURSE, INDUCED IN PL/J MICE BY MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-DERIVED PEPTIDE - PRELIMINARY-ANALYSIS OF MOG T-CELL EPITOPES [J].
DEROSBO, NK ;
MENDEL, I ;
BENNUN, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (04) :985-993
[5]   SUSCEPTIBILITY TO PROTEOLIPID APOPROTEIN AND ITS ENCEPHALITOGENIC DETERMINANTS IN MICE [J].
ENDOH, M ;
KUNISHITA, T ;
NIHEI, J ;
NISHIZAWA, M ;
TABIRA, T .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1990, 92 (04) :433-438
[6]  
Fazakerley J.K., 1997, MOL BIOL MULTIPLE SC, P255
[7]  
FAZAKERLEY JK, 1983, CLIN EXP IMMUNOL, V52, P115
[8]   AMINO-ACID HOMOLOGY BETWEEN THE ENCEPHALITOGENIC SITE OF MYELIN BASIC-PROTEIN AND VIRUS - MECHANISM FOR AUTOIMMUNITY [J].
FUJINAMI, RS ;
OLDSTONE, MBA .
SCIENCE, 1985, 230 (4729) :1043-1045
[9]   MINIMUM STRUCTURAL REQUIREMENTS FOR PEPTIDE PRESENTATION BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES - IMPLICATIONS IN INDUCTION OF AUTOIMMUNITY [J].
GAUTAM, AM ;
LOCK, CB ;
SMILEK, DE ;
PEARSON, CI ;
STEINMAN, L ;
MCDEVITT, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) :767-771
[10]   Late complications of immune deviation therapy in a nonhuman primate [J].
Genain, CP ;
Abel, K ;
Belmar, N ;
Villinger, F ;
Rosenberg, DP ;
Linington, C ;
Raine, CS ;
Hauser, SL .
SCIENCE, 1996, 274 (5295) :2054-2057